Home › Funds › Whitefort Capital Management, LP › ROIV

Whitefort Capital Management, LP position in ROIV

ROIVANT SCIENCES LTD · Health Care

Whitefort Capital Management, LP reported holding 1,019,000 shares of ROIV (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$36.1M, representing 9.21% of its reported portfolio and ranking #2 among its reported holdings. Whitefort Capital Management, LP has disclosed ROIV holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)1.02M sh
Reported value held$36.06M
Portfolio Weight9.21%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Whitefort Capital Management, LP's ROIV position evolved

Whitefort Capital Management, LP first disclosed a stake in ROIV in Q4 2023 at 1,591,000 shares (US$17.9M). The position peaked in Q3 2025 at 3,532,000 shares, worth US$53.4M. Across 11 filings, Whitefort Capital Management, LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,019,000 shares valued at US$36.1M — a reduction of -400,000 shares quarter over quarter.. Notable position changes include a 50% increase in Q1 2024 (shares were roughly flat over the following quarter), a 43% increase in Q1 2025 (shares rose 12% over the following quarter), a 40% trim in Q4 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.59M $17.87M New
Q1 2024 2.39M $25.20M Add
Q2 2024 2.39M $25.27M Hold
Q3 2024 2.39M $27.59M Hold
Q4 2024 2.39M $28.29M Hold
Q1 2025 3.41M $34.42M Add
Q2 2025 3.88M $43.75M Add
Q3 2025 3.53M $53.44M Reduce
Q4 2025 2.12M $46.00M Reduce
Q1 2026 1.42M $39.31M Reduce
Q2 2026 1.02M $36.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 64 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Whitefort Capital Management, LP held ROIV?

Whitefort Capital Management, LP has disclosed ROIV holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Whitefort Capital Management, LP's current position in ROIV?

As of Q2 2026, Whitefort Capital Management, LP holds 1.02M shares of ROIV (ROIVANT SCIENCES LTD), valued at $36.06M, representing 9.21% of its reported portfolio and ranking #2.

Has Whitefort Capital Management, LP been buying or selling ROIV?

In the latest 13F filing (Q2 2026), Whitefort Capital Management, LP reduced its position in ROIV. The position peaked in Q3 2025 at 3.53M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.